Sunday, November 22, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
News articleYahoo Finance· February 11, 2026

Asthma Drugs Market to Reach USD 41.18 Billion by 2035 | Biologic Therapies Accelerate Shift Toward Targeted Treatment Says Astute Analytica

View original at finance.yahoo.com
“This momentum continued into the fourth quarter, where sales reached EUR 3,458 million (USD 3,800 million).”
Verbatim excerpt from the source · Yahoo Finance · short snapshot: read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • North America dominated the global market, accounting for the largest share of 47% in 2025

    80% confidence
  • The market is bifurcating, with innovation focused on severe phenotypes and smart delivery, while policy shifts mandate affordability for mass-market generic access

    80% confidence
  • Asthma accounts for 1.4 million emergency department visits and 94,000 hospital inpatient stays annually in the US

    80% confidence
  • The direct cost of asthma care is estimated at USD 3,728 per person annually

    80% confidence
  • 3,517 asthma deaths were reported in the most recent US data

    80% confidence
  • High-value biologic therapies are overtaking traditional treatments, driving revenue despite pricing pressures on standard inhalers

    80% confidence
  • India reports 34 million asthma cases, creating massive demand for affordable generic inhalers

    80% confidence
  • The global smart inhaler market was valued at USD 1.53 billion in 2024 and could reach USD 7.9 billion by 2030

    80% confidence
  • China's Volume-Based Procurement (VBP) has slashed generic prices by ~50%, forcing multinationals to abandon legacy generic margins in favor of introducing innovative biologics to the self-pay and private insurance tiers

    80% confidence
  • The FDA approved 50 novel drugs in 2024

    80% confidence
  • The global asthma drugs market size was valued at USD 26.52 billion in 2025 and is projected to hit the market valuation of USD 41.18 billion by 2035 at a CAGR of 4.50% during the forecast period 2026–2035

    80% confidence
  • There are 4.7 million children with asthma in the US, contributing to a total affected population of 24.9 million

    80% confidence

Cited in these Via News reports